| AChE | Acetylcholinesterase |
| AD | Alzheimer’s disease |
| AMPK | AMP-activated protein kinase |
| ATF3 | Activating transcription factor 3 |
| BuChE | Butylcholinesterase |
| CAM | Complementary and alternative medicine |
| CDK1 | Cyclin Dependent Kinase 1 |
| COX-2 | Cyclooxygenase-2 |
| CYP2B6 | Cytochrome P450 2B6 |
| CYP3A4 | Cytochrome P450 3A4 |
| DISC | Death-inducing signaling complex |
| DNMT | DNA methyltransferase |
| DR | Death receptor |
| EGFR | Epidermal growth factor receptor |
| ERK | Extracellular signal-regulated kinase |
| FADD | Fas-associated death domain |
| FOXO3a | Forkhead box class O 3a |
| GSK-3β | Glycogen synthase kinase 3 beta |
| HDAC | Histone deacetylase |
| IKK | I kappa B kinase |
| JNK | Jun N-terminal kinase |
| LPS | Lipopolysaccharide |
| MAPK | Mitogen-activated protein kinase |
| mTOR | Mechanistic target of rapamycin |
| NAG-1 | (NSAID) activated gene-1 |
| NF-κB | Nuclear factor-kappa B |
| PARP | Poly ADP-ribose polymerase |
| PI3K | Phosphoinositide 3-kinase |
| PKC | Protein kinase C |
| ROS | Reactive oxygen species |
| SAR | Structure–activity relationship |
| TLR4 | Toll-like receptor 4 |
| TNFR1 | Tumor necrosis factor receptor 1 |
| TNF-α | Tumor necrosis factor-α |
| TRADD | TNFR1-associated death domain protein |
| ULK1 | Unc-51 Like Autophagy Activating Kinase 1 |